Cutaquig Purple Book BLA 125668
- BLA number
- 125668
- Proprietary names
- Cutaquig
- Proper names
- Immune Globulin Subcutaneous (Human)-hipp
- Applicant
- Octapharma Pharmazeutika Produktionsges.m.b.H.
- Center
- CBER
- First observed release
- 2020-08-01
- Latest observed release
- 2026-06-01
- Newest archive release
- 2026-06-01
- FDA patent list
- No patents listed in the captured FDA patent list; source updated 2025-06-11
- Coverage
- Present in newest release
Latest Known Product Presentations#
Product, Proprietary name, Proper name table| Product | Proprietary name | Proper name | License type | Strength | Dosage form | Route | Presentation | Marketing | Licensure | Approval | Patent list provided |
|---|
| 001 | Cutaquig | Immune Globulin Subcutaneous (Human)-hipp | 351(a) | 1.65G/10 ML | Solution | Subcutaneous | Single-Dose Vial | Rx | Licensed | 2018-12-12 | |
| 002 | Cutaquig | Immune Globulin Subcutaneous (Human)-hipp | 351(a) | 3.3G/20 ML | Solution | Subcutaneous | Single-Dose Vial | Rx | Licensed | 2018-12-12 | |
| 003 | Cutaquig | Immune Globulin Subcutaneous (Human)-hipp | 351(a) | 1G/6ML | Solution | Subcutaneous | Vial | Rx | Licensed | 2018-12-12 | |
| 004 | Cutaquig | Immune Globulin Subcutaneous (Human)-hipp | 351(a) | 2G/12ML | Solution | Subcutaneous | Single-Dose Vial | Rx | Licensed | 2018-12-12 | |
| 005 | Cutaquig | Immune Globulin Subcutaneous (Human)-hipp | 351(a) | 8G/48ML | Solution | Subcutaneous | Single-Dose Vial | Rx | Licensed | 2018-12-12 | |
| 006 | Cutaquig | Immune Globulin Subcutaneous (Human)-hipp | 351(a) | 4G/24ML | Solution | Subcutaneous | Single-Dose Vial | Rx | Licensed | 2018-12-12 | |
Published Patent List#
No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.
Official Monthly Change Events#
Release, Event, Product table| Release | Event | Product | Name | License type | Status | Applicant |
|---|
| 2021-05-01 | U | 001 | Cutaquig | 351(a) | Rx | Octapharma Pharmazeutika Produktionsges.m.b.H. |
| 2021-05-01 | U | 002 | Cutaquig | 351(a) | Rx | Octapharma Pharmazeutika Produktionsges.m.b.H. |
| 2021-05-01 | U | 003 | Cutaquig | 351(a) | Rx | Octapharma Pharmazeutika Produktionsges.m.b.H. |
| 2021-05-01 | U | 004 | Cutaquig | 351(a) | Rx | Octapharma Pharmazeutika Produktionsges.m.b.H. |
| 2021-05-01 | U | 005 | Cutaquig | 351(a) | Rx | Octapharma Pharmazeutika Produktionsges.m.b.H. |
| 2021-05-01 | U | 006 | Cutaquig | 351(a) | Rx | Octapharma Pharmazeutika Produktionsges.m.b.H. |
| 2020-08-01 | R | 001 | Cutaquig | 351(a) | Rx | Octapharma Pharmazeutika Produktionsges.m.b.H. |
| 2020-08-01 | R | 002 | Cutaquig | 351(a) | Rx | Octapharma Pharmazeutika Produktionsges.m.b.H. |
| 2020-08-01 | R | 003 | Cutaquig | 351(a) | Rx | Octapharma Pharmazeutika Produktionsges.m.b.H. |
| 2020-08-01 | R | 004 | Cutaquig | 351(a) | Rx | Octapharma Pharmazeutika Produktionsges.m.b.H. |
| 2020-08-01 | R | 005 | Cutaquig | 351(a) | Rx | Octapharma Pharmazeutika Produktionsges.m.b.H. |
| 2020-08-01 | R | 006 | Cutaquig | 351(a) | Rx | Octapharma Pharmazeutika Produktionsges.m.b.H. |
Observed Product State History#
Release, Product, Name table| Release | Product | Name | License type | Marketing | Licensure | Approval |
|---|
| 2020-08-01 | 001 | Cutaquig | 351(a) | Rx | Licensed | 2018-12-12 |
| 2020-08-01 | 002 | Cutaquig | 351(a) | Rx | Licensed | 2018-12-12 |
| 2020-08-01 | 003 | Cutaquig | 351(a) | Rx | Licensed | 2018-12-12 |
| 2020-08-01 | 004 | Cutaquig | 351(a) | Rx | Licensed | 2018-12-12 |
| 2020-08-01 | 005 | Cutaquig | 351(a) | Rx | Licensed | 2018-12-12 |
| 2020-08-01 | 006 | Cutaquig | 351(a) | Rx | Licensed | 2018-12-12 |